Sort by:
Keyphrases
Anticancer Properties
14%
Bone Resorption
100%
Calcitonin Receptor
14%
Calcium Oscillations
14%
Cancer Development
14%
Cathepsin K
14%
Cell Apoptosis
14%
Cell Differentiation
14%
Cell Growth
14%
Cellular Systems
14%
Common Complications
14%
GF109203X
100%
Growth Differentiation
14%
In Cancer
14%
Inhibitor Compound
14%
Mouse Bone Marrow Cells
28%
NF-B
100%
NFATC Transcription Factors
14%
NFATc1
14%
Osteoclast Activation
14%
Osteoclast Activity
28%
Osteoclast Formation
42%
Osteoclast Function
14%
Osteoclast Progenitors
14%
Osteoclastic
14%
Osteoclastogenesis
100%
Osteolysis
14%
Osteolytic Bone Disease
14%
Osteolytic Disease
14%
Process-based
14%
Protein Kinase
28%
Protein Kinase C Inhibitor
100%
Proton Pump
14%
Reduced Expression
14%
Tartrate-resistant Acid Phosphatase
14%
Therapeutic Blockade
14%
Therapeutic Potential
14%
Vacuolar H+-ATPase (V-ATPase)
14%
Medicine and Dentistry
Acid Phosphatase Tartrate Resistant Isoenzyme
16%
Bone Disease
16%
Bone Marrow Cell
33%
Calcitonin Receptor
16%
calcium activated,phospholipid dependent protein kinase
33%
Calcium Signaling
16%
Cancer
16%
Cathepsin K
16%
Cell Growth
16%
Diseases
16%
Malignant Neoplasm
33%
Osteoclast
33%
Osteoclast Activity
50%
Osteoclast Differentiation Factor
100%
Osteoclastogenesis
100%
Osteolysis
100%
Programmed Cell Death
16%
Protein Kinase C Inhibitor
100%
Proton Pump
16%
Receptor
16%
Transcription Factor NFAT
16%
V-ATPase
16%
Biochemistry, Genetics and Molecular Biology
Anticancer
16%
Calcitonin Receptor
16%
calcium activated,phospholipid dependent protein kinase
100%
Calcium Signaling
16%
Cathepsin K
16%
Cell Growth
16%
NFAT
100%
Osteoclast
33%
Osteoclast Activity
50%
Osteoclastogenesis
100%
Osteolysis
100%
Programmed Cell Death
16%
Proton Pump
16%
RANKL
100%
Tartrate-Resistant Acid Phosphatase
16%
Transcription Factor NFAT
16%
V-ATPase
16%
Immunology and Microbiology
Bone Marrow Cell
33%
Calcitonin
16%
Calcium Signaling
16%
Cell Growth
16%
NFAT
100%
Osteoclast
33%
Osteoclast Activity
50%
Osteoclastogenesis
100%
Osteolysis
100%
Phosphatase
16%
Programmed Cell Death
16%
Protein Kinase C
100%
RANKL
100%
Transcription Factor NFAT
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acid Phosphatase Tartrate Resistant Isoenzyme
16%
Adenosine Triphosphatase
16%
Bone Disease
16%
Calcitonin Receptor
16%
calcium activated,phospholipid dependent protein kinase
33%
Cathepsin K
16%
Diseases
16%
Malignant Neoplasm
33%
Osteoclast Differentiation Factor
100%
Protein Kinase C Inhibitor
100%
Proton Pump
16%
Receptor
16%
Transcription Factor NFAT
16%